Login

Tim Fitzpatrick, CEO and Co-Founder of IKONA Health, discusses their innovative kidney education platform designed for improved learning outcomes. 00:10:00

Share On Facebook Share On Twitter

David Cho is CEO of IKONA Partners

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:00:00
Silvi Rouskin Assistant Professor of Microbiology, HMS
00:10:00
Building Efficiency: Exploring Thermomur® Construction
00:10:00
leading fund investing in passionate Asian and Pacific Islander entrepreneurs|Bing Chen,Executive Chairman,Gold House Ventures
00:10:00
Strategic Priorities at Goldman Sachs: Insights from Investor Day 2020
00:10:00
Jonah Goldberg: The Constraints of Conservatism
00:10:00
Renewable Energy Innovator Explores Carbon Abatement Solutions and Profitability | Dr Jessica North, CEO, Lgi Ltd.
00:10:00
Castings PLC is the UK's premier iron casting and machining firm, supplying cast parts to the truck and automotive sectors.
00:10:00
Empowering Women in Mining: Angela Vasconcelos' Call for Inclusion and Diversity
00:10:00
Vox Royalty CEO Discusses 2023 Growth and Future Outlook
00:10:00
Join Elizabeth Burton, MD & Client Investment Strategist at Goldman Sachs Asset Management, as she navigates the complexities of the fundraising climate.
00:10:00
TCW CEO's Realistic Outlook: Navigating Market Pessimism Amidst Lingering Positivity | Katie Koch, CEO , TCW Group.
00:10:00
LADENBURG THALMANN ASSET MANAGEMENT|Philip S. Blancato, President,Ladenburg Thalmann Asset Management Inc

© 2026 Nehu